Cycling for people with type 1 diabetes

Size: px
Start display at page:

Download "Cycling for people with type 1 diabetes"

Transcription

1 Ian W Gallen Consultant Physician and Endocrinologist, Diabetes Centre, Wycombe Hospital, High Wycombe, UK Correspondence to: Ian W Gallen, Consultant Physician and Endocrinologist, Diabetes Centre, Wycombe Hospital, High Wycombe HP11 2TT, UK; ian.gallen@buckshealthcare.nhs.uk Received: 31 May 2013 Accepted in revised form: 5 July 2013 Abstract Cycling is increasing in popularity for both recreational and practical purposes. Marked changes in blood glucose are seen during and following cycling, with risk of hypoglycaemia. There is now an extensive body of clinical and research evidence to assist the clinician when advising the person with type 1 diabetes mellitus, to help people manage diabetes and exercise more effectively. Fortuitously, much of the research evidence is based on cycling. Copyright 2013 John Wiley & Sons. Practical Diabetes 2013; 30(7): Key words diabetes; type 1 diabetes; cycling; insulin treatment; hypoglycaemia; insulin infusion pump therapy; continuous glucose monitoring Introduction Cycling has increased in popularity over the last few years, and anyone travelling around at the weekends cannot fail to be impressed by the sheer number of recreational cyclists, some of whom are somewhat unfairly described by the acronym MAMIL (middle-aged men in Lycra). Another powerful force in the development of cycling is the move towards sustainable transport. As the cost of the commute to and from work or education increases, and with the increase in safer dedicated cycle lanes, cycling becomes a rational choice for personal transport. Where does this leave the person with type 1 diabetes? Strenuous physical activity may cause difficulties in maintaining glycaemic control which may make managing diabetes and cycling challenging. However, there is now an extensive body of clinical and research evidence to assist the clinician when advising the person with type 1 diabetes (T1DM) who wishes to cycle. Exercise physiology in health Cycling is predominantly an endurance or aerobic exercise. What this means is that the exercise is sub-maximal, and that fuels consumed during exercise are fully oxidised, rather than partly metabolised requiring excess postexercise oxygen consumption. This does not mean that the exercising muscles are working completely aerobically, but does mean that any excess muscle lactate production from exercising muscle is taken up by less exercising muscles and by other tissues to be converted to glucose for storage or oxidation. It is helpful to think of the example of a cycling road race. If one imagines the Peloton crossing the plains during the Tour de France, the cyclists are working at the top of their aerobic capacity. They have achieved this through training which increases the cardiovascular capacity to deliver oxygen to predominantly the leg muscles, the capacity of the blood to carry oxygen, and the ability of the liver and kidney to uptake lactic acid. They will be oxidising relatively little glucose, instead relying on fuels derived from the fat stores. At the start of cycling the muscles use glucose as their primary fuel, derived from muscle glycogen stores. As these stores are depleted, a balance develops between hepatic glucose production 1,2 and uptake by exercising muscle. This response is controlled by the endocrine system (Table 1). Exercise reduces insulin secretion through sympathetic nervous system activation 3,4 and the change in the ratio of glucagon to insulin at the liver promotes hepatic glucose production. Exerciseinduced translocation of GLUT-4 receptors to the cell surface enables increased muscle glucose uptake even with falling insulin levels. 5 Clearly, in some circumstances cycling can be anaerobic. Returning to our example of the road race, as the cyclists reach the challenging climb of the stage, the work increases, lactate production now exceeds uptake, and exercise must be limited. Even while global oxygen PRACTICAL DIABETES VOL. 30 NO. 7 COPYRIGHT 2013 JOHN WILEY & SONS 273

2 uptake may be sufficient, local muscle groups may have insufficient delivery, so that muscle is unable to utilise the full potential of the carbohydrate fuel available. Lactate acid production increases as a result of this and other fuels are utilised less. Lactate homeostasis is maintained with excess lactate production being taken up by other tissues. As workload increases, lactate acid production exceeds uptake (the lactate threshold), and blood lactate levels increase. 6,7 Ultimately, exercise will be limited by rising lactate levels, but the tolerance to increased lactate levels to enable maximal performance does vary between individuals. Eventually, lactate levels rise to such a level which cannot be tolerated and the unpleasant symptoms of aching muscles, pounding heart and shortness of breath pounds make it impossible to exercise any longer at that intensity. Glucose production is increased by seven to eight times to achieve the required work output, with circulating catecholamines increasing to between 14 and 18 times their baseline level. 8,9 High performing cyclists have a high lactate threshold and, when this is exceeded, have high lactate tolerance. Physical training therefore increases physical fitness by increasing oxygen delivery to muscle through improved cardio-respiratory responses to exercise, increased glucose and fuel uptake into muscle and by improvements in lactate uptake by the liver, kidney and the other less exercising muscles. These adaptations combine to raise the lactate threshold. Ultimately, exercise capacity can be further increased by increasing the level of lactate tolerance. These principles are similar for people with or without T1DM. Effect of exercise on glycaemic control in type 1 diabetes The endocrine and resultant metabolic responses during and following exercise are altered in T1DM (Table 2). These changes have been reviewed extensively but are summarised as follows. 10 Injected insulin sits in subcutaneous depots, from where absorption continues or may actually increase during exercise. As Endocrine response Endurance Intense exercise Rest (aerobic exercise) (anaerobic) Insulin or Glucagon Catecholamines Growth hormone Cortisol Table 1. Endocrine response to exercise Endocrine response Endurance Intense exercise Rest (aerobic exercise) (anaerobic) Insulin or or or Glucagon or or or Catecholamines Growth hormone Cortisol Table 2. Endocrine response to exercise in type 1 diabetes a result there may be comparatively excessive levels relative to the glucose concentration. As previously described, exercise induces noninsulin dependent translocation of GLUT-4 receptors to the cell surface which increase muscle glucose uptake, even with low insulin levels. All parts of the counter-regulatory response to endurance exercise are impaired, and the insulin to glucagon ratio presented to the liver is inappropriately high, with glucose production not increasing adequately during exercise to cope with the increased fuel requirement. There is inappropriately high glucose uptake by non-exercising muscles and other tissues. The catecholamine and growth hormone responses to exercise are also deficient. This will reduce glucose production. As a result, during prolonged exercise, the relatively high ambient plasma insulin levels, increased non-insulin mediated glucose uptake when combined with a deficient counter-regulatory hormonal response will provoke a marked fall in blood glucose. Furthermore, there is less release of other fuels and so a person with T1DM tends to oxidize excessive glucose, rather than fatty acids or ketones, which may contribute to excess fatigue. To some extent, the endurance cyclist has almost a similar endocrine state as the person with untreated T1DM, but does not accumulate glucose and ketone bodies because these are all oxidized. This suggests that the optimum management of people with T1DM during exercise to maximise performance and reduce the risk of hypoglycaemia may be to replicate this physiological hypo-insulinaemic state during exercise. However, insulin levels must be restored quickly to deal with postexercise hyperglycaemia. Intense exercise produces a greater counter-regulatory hormone response than sub-maximal end - urance exercise in T1DM. 6,7,11 13 Intermittent high-intensity exercise is associated with a lesser fall in glucose than moderate exercise of a similar workload. When people with T1DM were exercised for 30 minutes by continuous sub-maximal exercise or with 4-second sprints performed every 2 minutes, the decline in blood glucose was less with the intense exercise. 274 PRACTICAL DIABETES VOL. 30 NO. 7 COPYRIGHT 2013 JOHN WILEY & SONS

3 Glucose levels remained stable during recovery, but continued to fall after sub-maximal exercise alone. The mechanism for this stabilisation of blood glucose levels appears to be mediated through increased secretion of catecholamines and growth hormone during early recovery after exercise. 14 Short periods of intense exercise performed before, or following, endurance exercise can also attenuate the decline in blood glucose that occurs following exercise. When a maximal 10-second cycling sprint was performed immediately following exercise of moderate intensity the fall in blood glucose was less in the 2 hours following exercise when compared to that observed following moderate-intensity exercise without the brief sprint. A similar protective effect is observed if the 10-second sprint is performed before continuous exercise. 11,12 This protective effect of highintensity exercise seems to be lost in the late post-exercise period. Nocturnal hypoglycaemia is more frequent following intermittent highintensity exercise than after moderate exercise. When glucose profiles were examined using continuous glucose monitoring during, and in the 20 hours after a 30-minute session of either intermittent high-intensity exercise or moderate-intensity exercise, glucose levels declined during both types of exercise. However, between midnight and 6:00 a.m. the glucose levels were significantly lower after the period of intermittent exercise, and the number of hypoglycaemic episodes was greater than after lower-intensity exercise. 15 Exogenous insulin treatment for T1DM therefore has significant effects on the endocrine response to exercise, and insulin levels may be inappropriate either during or following cycling. While blood glucose levels generally fall rapidly during cycling, there are some circumstances in which they may remain stable or even increase. The interaction between hypoglycaemia and exercise Hypoglycaemia can be difficult to detect during exercise as many of the symptomatic manifestations of hypoglycaemia (sweating and increased heart rate) are similar to those experienced by an exercising athlete. There are complex interactions between exercise and hypoglycaemia. Hypoglycaemia before cycling reduces the counter-regulatory hormone response with exercise, and thus must increase the risk of further hypoglycaemia. 16 A person with T1DM who has experienced an episode of hypoglycaemia on the day before the period of exercise will therefore need to ingest more glucose to avoid developing hypoglycaemia during subsequent exercise. 17 In a similar way, exercise also impairs the counter-regulatory response and awareness of later hypoglycaemia. 18,19 Epinephrine, pancreatic polypeptide, muscle sympathetic neural activity and endogenous glucose production were all significantly lower during hypoglycaemia induced on the subsequent day, after 90 minutes of moderate sub-maximal exercise, in comparison with hypoglycaemia induced in control subjects with T1DM who had rested. This exercise-induced counter-regulatory failure can occur very rapidly, increasing the risk of hypoglycaemia developing within hours in T1DM. 19 It is noteworthy that the risk of hypoglycaemia in males following exercise seems to be higher than that for females as the counter-regulatory response to exercise following hypoglycaemia is relatively preserved in women. 20 Hypoglycaemia is also more likely to occur and less likely to be recognised during sleep following a preceding period of exercise. One of the earliest observations was that hypoglycaemia occurs 6 15 hours after the completion of unusually strenuous exercise and was nocturnal. In more than half the cases the hypoglycaemia resulted in loss of consciousness or seizures and necessitated treatment with subcutaneous glucagon or intravenous glucose and/or emergency medical assistance. Hypoglycaemia was not limited to people with good or strict glycaemic control and often occurred after a single bout of exercise in individuals who were unaccustomed to physical activity or in athletic patients who were making the transition from an untrained to a trained state. 21 The mechanism for this increased risk of nocturnal hypoglycaemia is multifactorial, being the result of the combination of increased nocturnal glucose disposal into skeletal muscle, 22 and impaired counter-regulatory resp - onse to hypoglycaemia following exercise. This risk is greater following alcohol ingestion, 23,24 and hypoglycaemia is less likely to be observed and treated in those who sleep alone, and is potentially life threatening. 25 Strategies to maintain euglycaemia during and after exercise What advice should be given to people who plan to cycle? The first advice must be to reduce day-to-day variation in insulin therapy with review of injection techniques, and to improve insulin dosage relative to carbohydrate intake. The interview should then explore the detail of any planned cycling intensity and duration, along with relationship to insulin treatment and food intake. With this information, prediction of likely change in glucose levels with planned cycling can be made. Several strategies can be adopted to maintain euglycaemia during and following exercise (Table 3). The mainstay of management remains ingestion of carbohydrate before and during exercise. It is important not to over-replace, as this results in hyperglycaemia. Simpler forms of carbohydrate, such as glucose, can be ingested regularly during exercise in an accessible form Evidence suggests that the ability to absorb glucose during exercise is limited to as little as 60g/hour. 33 Typically a 70kg adult may be ingesting 20g of glucose every 20 minutes during exercise. 34 Where exercise is for less than 1 hour, simple carbo - hydrates should be consumed. When exercise is more prolonged, more palatable complex foods can be ingested. People taking multiple daily insulin (MDI) injections can adjust their pre-exercise bolus insulin dose and take extra carbohydrate during exercise to reduce the risk of hypoglycaemia. 28,35,36 Lower premeal insulin doses were associated with a lower incidence of exerciseinduced hypoglycaemia, but with PRACTICAL DIABETES VOL. 30 NO. 7 COPYRIGHT 2013 JOHN WILEY & SONS 275

4 Adjustment Endurance (aerobic) exercise Intense (anaerobic exercise) Bolus dose insulin reduction Basal morning insulin dose reduction in multiple daily injection regimens before exercise Basal nocturnal insulin dose reduction in multiple daily injection regimens following exercise to reduce nocturnal hypoglycaemia Altered continuous subcutaneous insulin infusion basal rate with exercise Pre-exercise carbohydrate intake Intra-exercise carbohydrate intake Post-exercise carbohydrate intake Pre- or post-exercise sprint Useful when exercise occurs within 90 minutes of bolus dose May be useful if on twice-daily basal injection, especially if exercise occurs less than every 3 days Useful especially if exercise occurs less than every 3 days Reduce basal rate to as low as 10% normal basal during exercise Only if blood glucose <8mM Typically 1g/kg/hr exercise up to 60g/hr Useful to reduce risk of hypoglycaemia and fatigue, with reduced dose of insulin Will help reduce hypoglycaemia May reduce hypoglycaemia during or following exercise Not helpful, but may require additional bolus dose during or following exercise Not helpful Useful especially if exercise occurs less than every 3 days Increased basal rate may be needed during exercise Not usually needed Not usually needed Useful to reduce risk of hypoglycaemia and fatigue, with reduced dose of insulin May increase hyperglycaemia Unlikely to be helpful Table 3. Strategies to promote euglycaemia during and following exercise some post-prandial hyperglycaemia. As a result, this is really only useful if exercise is to take place within 90 minutes of the ultra short-acting insulin dose. Continuous subcutaneous insulin infusion (CSII) offers the capacity to modify the basal infusion rate by small increments and to obtain an effect relatively quickly. The subcutaneous reservoir of insulin is very small, and CSII provides an ability to give multiple additional bolus doses of insulin without needing to give additional injections. With an insulin pump, it is possible to reduce or suspend insulin infusion during exercise. We have found CSII therapy very useful in cyclists and there are some data to support this. In an observational study of aerobic exercise and recovery performed by people with T1DM treated with either MDI injections or CSII, interstitial glucose levels were compared during 45 minutes of standardised aerobic exercise (cycling or running at 60% peak aerobic capacity) and during 6 hours post exercise. Both MDI and CSII groups had similar reductions in glucose levels during exercise. However, responses in early and late recovery differed, with those using MDI having greater increases in glucose throughout recovery compared with individuals with CSII. Two-thirds of the MDI patients experienced late-onset post-exercise hyperglycaemia, compared with only a few of the CSII patients. The use of CSII seems to help limit post-exercise hyperglycaemia compared with MDI therapy and was not associated with increased risk for post-exercise late-onset hypoglycaemia. 37 There are few data currently available to indicate by how much the insulin infusion rates may have to be modified or the most appropriate time at which these changes in rate should be made. However, our observations are that a large reduction in insulin infusion rate or even complete suspension is required at least 30 minutes before commencing prolonged cycling. For people treated with CSII therapy, post-exercise adjustment of the basal rate of insulin infusion is feasible. From clinical experience, in people who take exercise less frequently than on alternate days, nocturnal hypoglycaemia can be limited without compromising overall glycaemic control (including morning fasting glucose readings). This is done by reducing the basal CSII rate during the night after the exercise. Follow - ing 60 minutes of exercise, the most effective rate adjustment appears to be a reduction in the basal insulin infusion rate of 25% during the postexercise period. A greater reduction of 50% of the basal insulin infusion rate during this post-exercise period was associated with elevated blood glucose levels. 38 A reduction in infusion rate of 25% is likely to be required in the late post-exercise period and also overnight. The advent of commercially available continuous glucose monitoring (CGMS) equipment may seem to offer a significant advance in the management of exercise and T1DM. Unfortunately, the correlation between the CGMS measurements and capillary blood glucose is not reliable during exercise and is not yet a useful tool for identifying significant changes in glucose, and particularly hypoglycaemia, in real time. 34,39 Current CGMS may have a role in alerting the user as to the trajectory and speed of fall of the glucose response to exercise. In contrast 276 PRACTICAL DIABETES VOL. 30 NO. 7 COPYRIGHT 2013 JOHN WILEY & SONS

5 to the difficulties experienced with the accuracy of CGMS values during exercise, a further development of technology offers the possibility of reduction in hypoglycaemia following exercise. In one study, a sensoraugmented insulin pump system was equipped with an automatic suspension of insulin delivery with exerciseinduced hypoglycaemia. The low glucose suspend (LGS) feature stops insulin delivery for 2 hours following a sensor glucose value 3.9mmol/L (70mg/dl). People with T1DM exercised until their plasma glucose value reached 4.7mmol/L (85mg/dl). When exercise sessions were done with the LGS feature turned on, the mean nadir and end glucose values were higher than when the feature was switched off. Automatic suspension of insulin delivery significantly reduced the duration and severity of exercise-induced hypoglycaemia without causing rebound hyperglycaemia. 40 Conclusions Cycling in people with type 1 diabetes can produce large changes in blood glucose, with hypoglycaemia likely and hyperglycaemia possible during and following exercise. There have been significant recent improvements in the knowledge of what underlies these changes and in appropriate management to support the maintenance of euglycaemia. With careful questioning of the type, timing, duration and intensity of cycling, detailed review of intake of food and timing of insulin injections, blood glucose control can be maintained. Nocturnal hypoglycaemia following exercise remains a concern, and planning is essential to reduce this risk. Further advances in insulin infusion pump therapy and continuous subcutaneous glucose monitoring are likely to be useful in the management of people with type 1 diabetes who want to exercise. With the support of a skilled clinician, there is no reason why people with type 1 diabetes should not be able to bike safely while maintaining good glycaemic control. Declaration of interests There are no conflicts of interest declared. References 1. Koivisto VA, Felig P. Effects of leg exercise on insulin absorption in diabetic patients. N Engl J Med 1978; 298: Petersen KF, et al. Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of type 1 diabetes. J Clin Endocrinol Metab 2004;89: Broadstone VL, et al. Alpha-adrenergic blockade improves glucose-potentiated insulin secretion in non-insulin-dependent diabetes mellitus. Diabetes 1987;36: Robertson RP, et al. A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. J Clin Invest 1976;57: Thorell A, et al. Exercise and insulin cause GLUT-4 translocation in human skeletal muscle. Am J Physiol 1999;277(4 Pt 1):E Marliss EB, et al. Glucoregulatory and hormonal responses to repeated bouts of intense exercise in normal male subjects. J Appl Physiol 1991;71: Marliss EB, et al. Gender differences in glucoregulatory responses to intense exercise. J Appl Physiol 2000;88: Sigal RJ, et al. Glucoregulation during and after intense exercise: effects of beta-adrenergic blockade in subjects with type 1 diabetes mellitus. J Clin Endocrinol Metab 1999;84: Sigal RJ, et al. The roles of catecholamines in glucoregulation in intense exercise as defined by the islet cell clamp technique. Diabetes 1996;45: Lumb AN, Gallen IW. Diabetes management for intense exercise. Curr Opin Endocrinol Diabetes Obes 2009;16(2): Bussau VA, et al. The 10-s maximal sprint: a novel approach to counter an exercise-mediated fall in glycemia in individuals with type 1 diabetes. Diabetes Care 2006;29: Bussau VA, et al. A 10-s sprint performed prior to moderate-intensity exercise prevents early post-exercise fall in glycaemia in individuals with type 1 diabetes. Diabetologia 2007;50: Guelfi KJ, et al. Effect of intermittent high-intensity compared with continuous moderate exercise on glucose production and utilization in individuals with type 1 diabetes. Am J Physiol Endocrinol Metab 2007;292(3):E Guelfi KJ, et al. The decline in blood glucose levels is less with intermittent high-intensity compared with moderate exercise in individuals with type 1 diabetes. Diabetes Care 2005;28: Maran A, et al. Continuous glucose monitoring reveals delayed nocturnal hypoglycemia after intermittent high-intensity exercise in nontrained patients with type 1 diabetes. Diabetes Technol Ther 2010;12: Galassetti P, et al. Effect of differing antecedent hypoglycemia on counterregulatory responses to exercise in type 1 diabetes. Am J Physiol Endocrinol Metab 2006;290(6):E Davis SN, et al. Effects of antecedent hypoglycemia on subsequent counterregulatory responses to exercise. Diabetes 2000;49: Sandoval DA, et al. Effects of low and moderate antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes. Diabetes 2004;53: Sandoval DA, et al. Acute, same-day effects of antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes mellitus. Am J Physiol Endocrinol Metab 2006;290(6):E Galassetti P, et al. Effect of sex on counterregulatory responses to exercise after antecedent hypoglycemia in type 1 diabetes. Am J Physiol Endocrinol Metab 2004;287(1):E MacDonald MJ. Postexercise late-onset hypoglycemia in insulin-dependent diabetic patients. Diabetes Care 1987;10: McMahon SK, et al. Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner. J Clin Endocrinol Metab 2007;92: Cheyne EH, et al. Influence of alcohol on cognitive performance during mild hypoglycaemia; implications for type 1 diabetes. Diabet Med 2004; 21: Richardson TB, et al. Day after the night before: Influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes. Diabetes Care 2005;28: Tattersall RB, Gill GV. Unexplained deaths of type 1 diabetic patients. Diabet Med 1991;8: Francescato MP, et al. Carbohydrate requirement and insulin concentration during moderate exercise in type 1 diabetic patients. Metabolism 2004; 53: Francescato MP, et al. Prediction of glucose oxidation rate during exercise. Int J Sports Med 2008;29: Mauvais-Jarvis F, et al. Glucose response to intense aerobic exercise in type 1 diabetes: maintenance of near euglycemia despite a drastic decrease in insulin dose. Diabetes Care 2003;26: Ramires PR, et al. Oral glucose ingestion increases endurance capacity in normal and diabetic (type I) humans. J Appl Physiol 1997;83: Riddell MC, et al. Glucose ingestion and substrate utilization during exercise in boys with IDDM. J Appl Physiol 2000;88: Tamis-Jortberg B, et al. Effects of a glucose polymer sports drink on blood glucose, insulin, and performance in subjects with diabetes. Diabetes Educ 1996;22: West DJ, et al. Isomaltulose improves postexercise glycemia by reducing CHO oxidation in T1DM. Med Sci Sports Exerc 2011;43: Jeukendrup AE, Jentjens R. Oxidation of carbohydrate feedings during prolonged exercise: Current thoughts, guidelines and directions for future research. Sports Med 2000;29: Gallen IW, et al. Fuelling the athlete with type 1 diabetes. Diabetes Obes Metab 2011; 13: Hernandez JM, et al. Fluid snacks to help persons with type 1 diabetes avoid late onset postexercise hypoglycemia. Med Sci Sports Exerc 2000;32: Rabasa-Lhoret R, et al. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro). Diabetes Care 2001;24: Yardley JE, et al. Insulin pump therapy is associated with less post-exercise hyperglycemia than multiple daily injections: an observational study of physically active type 1 diabetes patients. Diabetes Technol Ther 2013;15: Sonnenberg GE, et al. Exercise in type 1 (insulindependent) diabetic patients treated with continuous subcutaneous insulin infusion. Prevention of exercise induced hypoglycaemia. Diabetologia 1990;33: Davison R, et al. Comparison of patient blood glucose monitoring with continuous blood glucose monitoring during exercise. Diabetic Med 2010; 27(Suppl 1):427 [poster 427 presented at Diabetes UK Annual Professional Conference, Liverpool, United Kingdom, March 2010]. 40. Garg S, et al. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the inclinic ASPIRE study. Diabetes Technol Ther 2012; 14: PRACTICAL DIABETES VOL. 30 NO. 7 COPYRIGHT 2013 JOHN WILEY & SONS 277

Olympic diabetes What have we learned over the last decade? Ian Gallen Jephcott Symposium 9 th May 2012

Olympic diabetes What have we learned over the last decade? Ian Gallen Jephcott Symposium 9 th May 2012 Olympic diabetes What have we learned over the last decade? Ian Gallen Jephcott Symposium 9 th May 2012 Diabetes and exercise Ian Gallen Challenges in the management SR s diabetes prior to 2000 Olympic

More information

15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016

15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016 15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016 Sponsored by: Abbott Diabetes Care and Lilly Diabetes Type 1 and exercise Royal Berkshire Hospital Centre for Diabetes and Endocrinology

More information

Case Study: Competitive exercise

Case Study: Competitive exercise Case Study: Competitive exercise 32 year-old cyclist Type 1 diabetes since age 15 Last HbA1 54 No complications and hypo aware On Humalog 8/8/8 and Levemir 15 Complains about significant hypoglycaemia

More information

Workshop 4 and 9 Helping Endurance Athletes Manage Diabetes Anne Peters, MD Saturday, February 18, :00 p.m. 3:30 p.m.

Workshop 4 and 9 Helping Endurance Athletes Manage Diabetes Anne Peters, MD Saturday, February 18, :00 p.m. 3:30 p.m. Workshop 4 and 9 Helping Endurance Athletes Manage Diabetes Anne Peters, MD Saturday, February 18, 2017 2:00 p.m. 3:30 p.m. The treatment of diabetes involves ensuring adequate delivery of fuel to muscle.

More information

Hypoglyceamia and Exercise

Hypoglyceamia and Exercise Hypoglyceamia and Exercise Noreen Barker Diabetes Specialist Nurse May 2016 Hypoglyceamia What is a hypo? Why are we concerned? Signs and symptoms Treatments Causes Hypo unawareness Managing diabetes and

More information

What systems are involved in homeostatic regulation (give an example)?

What systems are involved in homeostatic regulation (give an example)? 1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS (Diabetes Mellitus Part 1): An Overview

More information

Fundamentals of Exercise Physiology and T1D

Fundamentals of Exercise Physiology and T1D COMPLIMENTARY CE Fundamentals of Exercise Physiology and T1D Jointly Provided by Developed in collaboration with 1 INTRODUCTION TO PHYSICAL ACTIVITY AND T1D 2 Many People with T1D Have Lower Levels of

More information

UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY

UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY 1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS An Overview WHAT IS HOMEOSTASIS? Homeostasis

More information

TYPE 1 DIABETES AND EXERCISE. Mark W Savage

TYPE 1 DIABETES AND EXERCISE. Mark W Savage TYPE 1 DIABETES AND EXERCISE Mark W Savage Acknowledgments Slides with a blue background are cropped and courtesy of both Eli Lilly and Company, and Dr Ian Gallen FRCP Consultant Diabetologist, Royal Berkshire

More information

Managing blood glucose and exercise in young people with Type 1 Diabetes. Dr Alistair Lumb Dr Taffy Makaya Anne Marie Frohock RD

Managing blood glucose and exercise in young people with Type 1 Diabetes. Dr Alistair Lumb Dr Taffy Makaya Anne Marie Frohock RD Managing blood glucose and exercise in young people with Type 1 Diabetes Dr Alistair Lumb Dr Taffy Makaya Anne Marie Frohock RD May 2018 www.ouh.nhs.uk/childrens-diabetes Plan Why might exercise be a challenge

More information

For youngsters and their families

For youngsters and their families For youngsters and their families Dr Alistair Lumb, Diabetologist Dr Taffy Makaya, Paediatric Consultant in Diabetes Anne Marie Frohock RD, Advanced Paediatric Dietitian. How much exercise should we be

More information

Presented by Dr. Bruce Perkins, MD MPH Dr. Michael Riddell, PhD

Presented by Dr. Bruce Perkins, MD MPH Dr. Michael Riddell, PhD Type 1 Diabetes and Exercise: Optimizing the Medtronic MiniMed Veo Insulin Pump and Continuous Glucose Monitoring (CGM) for Better Glucose Control 1,2 for Healthcare Professionals Presented by Dr. Bruce

More information

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) SETTING FOR STAFF PATIENTS Medical and nursing staff Children and young

More information

The design and evaluation of a self-management algorithm for people with type 1 diabetes performing moderate intensity exercise

The design and evaluation of a self-management algorithm for people with type 1 diabetes performing moderate intensity exercise The design and evaluation of a self-management algorithm for people with type 1 diabetes performing moderate intensity exercise Jacqui Charlton MRes, BSc, PgCTLHE, RGN, Lecturer and Specialist Nurse in

More information

Ensuring Safe Physical Activity in Children and Adolescents With Type 1 Diabetes

Ensuring Safe Physical Activity in Children and Adolescents With Type 1 Diabetes Ensuring Safe Physical Activity in Children and Adolescents With Type 1 Diabetes FACULTY ADVISOR Lori Laffel, MD, MPH Professor, Pediatrics Harvard Medical School Chief, Pediatric, Adolescent and Young

More information

Physical Activity. What happens to blood glucose levels during exercise?

Physical Activity. What happens to blood glucose levels during exercise? Physical Activity Being physically active every day is important for healthy growth and development. Regular exercise can help maintain a healthy weight, reduce blood pressure and improve blood lipid profile,

More information

The effect of nutritional strategy on the distance covered during a simulated Sportive-like event

The effect of nutritional strategy on the distance covered during a simulated Sportive-like event Go Further Research Study Page 1 The effect of nutritional strategy on the distance covered during a simulated Sportive-like event Introduction The performance advantage gained by ingestion of carbohydrate

More information

ESPEN Congress Madrid 2018

ESPEN Congress Madrid 2018 ESPEN Congress Madrid 2018 Dysglycaemia In Acute Patients With Nutritional Therapy Mechanisms And Consequences Of Dysglycaemia In Patients Receiving Nutritional Therapy M. León- Sanz (ES) Mechanisms and

More information

hypoglycaemia unawareness keystone 18 July 2014

hypoglycaemia unawareness keystone 18 July 2014 hypoglycaemia unawareness keystone 18 July 2014 Hypoglycaemia unawareness: ( Impaired awareness of hypoglycaemia ) Philip Home Newcastle University Philip Home Duality of interest Manufacturers of glucose-lowering

More information

ENERGY FROM INGESTED NUTREINTS MAY BE USED IMMEDIATELY OR STORED

ENERGY FROM INGESTED NUTREINTS MAY BE USED IMMEDIATELY OR STORED QUIZ/TEST REVIEW NOTES SECTION 1 SHORT TERM METABOLISM [METABOLISM] Learning Objectives: Identify primary energy stores of the body Differentiate the metabolic processes of the fed and fasted states Explain

More information

CHAPTER 10: Diet and nutrition & effect on physical activity and performance Practice questions - text book pages

CHAPTER 10: Diet and nutrition & effect on physical activity and performance Practice questions - text book pages QUESTIONS AND ANSWERS CHAPTER 10: Diet and nutrition & effect on physical activity and performance Practice questions - text book pages 144-145 1) Complex carbohydrates do not include: a. lipids. b. triglycerides.

More information

Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption),

Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption), Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption), in which blood glucose predominantly originates from

More information

Advances in Diabetes Care Technologies

Advances in Diabetes Care Technologies 1979 Advances in Diabetes Care Technologies 2015 Introduction Insulin pump use: ~ 20% - 30% of patients with T1DM < 1% of insulin-treated patients with T2DM 2007 FDA estimates ~375,000 insulin pumps for

More information

PREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS)

PREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS) PREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS) Pathways for Future Treatment and Management of Diabetes H. Peter Chase, MD Carousel of Hope Symposium Beverly Hilton, Beverly

More information

Counting the Carbs, Fat and Protein in Type 1 Diabetes Translating the Research into Clinical Practice

Counting the Carbs, Fat and Protein in Type 1 Diabetes Translating the Research into Clinical Practice Welcome to Allied Health Telehealth Virtual Education Counting the Carbs, Fats and Protein in Type 1 Diabetes Translating the Research into Clinical Practice Dr Carmel Smart, PhD Senior Specialist Paediatric

More information

Exercise management in type 1 diabetes: a consensus statement

Exercise management in type 1 diabetes: a consensus statement Exercise management in type 1 diabetes: a consensus statement Michael C Riddell, Ian W Gallen, Carmel E Smart, Craig E Taplin, Peter Adolfsson, Alistair N Lumb, Aaron Kowalski, Remi Rabasa-Lhoret, Rory

More information

Dedicated To. Course Objectives. Diabetes What is it? 2/18/2014. Managing Diabetes in the Athletic Population. Aiden

Dedicated To. Course Objectives. Diabetes What is it? 2/18/2014. Managing Diabetes in the Athletic Population. Aiden Managing Diabetes in the Athletic Population Dedicated To Aiden Michael Prybicien, LA, ATC, CSCS, CES, PES Athletic Trainer, Passaic High School Overlook Medical Center & Adjunct Faculty, William Paterson

More information

The In-Clinic Close Loop Experience in the US

The In-Clinic Close Loop Experience in the US The In-Clinic Close Loop Experience in the US Keystone Symposium, Practical Ways to Achieve Targets in Diabetes Care July 14, 2012 Francine Ratner Kaufman, MD Chief Medical Officer, VP Global Medical,

More information

SHEDDING NEW LIGHT ON CARBOHYDRATES AND EXERCISE

SHEDDING NEW LIGHT ON CARBOHYDRATES AND EXERCISE SHEDDING NEW LIGHT ON CARBOHYDRATES AND EXERCISE Dr Javier Gonzalez Department for Health, University of Bath, UK. j.t.gonzalez@bath.ac.uk Van Loon (2012) Energy Stores FAT: >100,000 kcal Van Loon (2012)

More information

What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes?

What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes? What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes? Dr. Fiona Wotherspoon Consultant in Diabetes and Endocrinology Dorset County Hospital Fiona.Wotherspoon@dchft.nhs.uk

More information

INJECTABLE THERAPIES IN DIABETES. Barbara Ann McKee Diabetes Specialist Nurse

INJECTABLE THERAPIES IN DIABETES. Barbara Ann McKee Diabetes Specialist Nurse INJECTABLE THERAPIES IN DIABETES Barbara Ann McKee Diabetes Specialist Nurse 1 Aims of the session Describe the different injectable agents for diabetes and when they would be used. Describe some common

More information

Artificial Pancreas Device System (APDS)

Artificial Pancreas Device System (APDS) Medical Policy Manual Durable Medical Equipment, Policy No. 77 Artificial Pancreas Device System (APDS) Next Review: October 2019 Last Review: October 2018 Effective: November 1, 2018 IMPORTANT REMINDER

More information

REVIEW PeptoPro in Sports Performance

REVIEW PeptoPro in Sports Performance REVIEW PeptoPro in Sports Performance Tammy Wolhuter, RD (SA) & Anne Till, RD(SA) From: Anne Till & Associates, Registered Dietitians 1. Nutrition and Sporting Performance Optimal and good nutrition is

More information

Carbohydrate (CHO) supplementation has long been known to improve endurance

Carbohydrate (CHO) supplementation has long been known to improve endurance Effect of a Electrolyte replacement beverage compared with a commercially available Carbohydrate supplement on the rate of fat oxidation during moderate-intensity cycle ergometry exercise INTRODUCTION

More information

Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus

Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus Version No. Changes Made Version of July 2018 V0.5 Changes made to the policy following patient engagement including: - the

More information

Placename CCG. Policies for the Commissioning of Healthcare

Placename CCG. Policies for the Commissioning of Healthcare Placename CCG Policies for the Commissioning of Healthcare Policy for the funding of insulin pumps and continuous glucose monitoring devices for patients with diabetes 1 Introduction 1.1 This document

More information

BEST 4 Diabetes. Optimisation of insulin module

BEST 4 Diabetes. Optimisation of insulin module BEST 4 Diabetes Optimisation of insulin module Confidence and competence Where would you rate yourself? Why do all of our patient not achieve optimal blood glucose control? Insulin Therapy Goals and Purpose

More information

INSULIN THERAY دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد

INSULIN THERAY دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد INSULIN THERAY DIABETES1 IN TYPE دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد Goals of management Manage symptoms Prevent acute and late complications Improve quality of life Avoid

More information

The Realities of Technology in Type 1 Diabetes

The Realities of Technology in Type 1 Diabetes The Realities of Technology in Type 1 Diabetes May 6, 2017 Rosanna Fiallo-scharer, MD Margaret Frederick, RN Disclosures I have no conflicts of interest to disclose I will discuss some unapproved treatments

More information

CHAPTER 2 FATIGUE AND RECOVERY

CHAPTER 2 FATIGUE AND RECOVERY SECTION A CHAPTER 2 FATIGUE AND RECOVERY 188 CHAPTER 2 FATIGUE AND RECOVERY Fatigue Effects of fatigue on performance Performance can be affected by muscle fatigue, the depletion of energy stores in muscle

More information

Artificial Pancreas Device Systems. Populations Interventions Comparators Outcomes. pump. pump

Artificial Pancreas Device Systems. Populations Interventions Comparators Outcomes. pump. pump Protocol Artificial Pancreas Device Systems (10130) Medical Benefit Effective Date: 04/01/18 Next Review Date: 01/19 Preauthorization Yes Review Dates: 03/15, 03/16, 03/17, 01/18 Preauthorization is required.

More information

Physical exercise and diabetes during childhood

Physical exercise and diabetes during childhood ACTA BIOMED 2006; 77; Suppl. 1: 18-25 Mattioli 1885 C O N F E R E N C E R E P O R T Physical exercise and diabetes during childhood Cosimo Giannini, A. Mohn, Francesco Chiarelli Paediatrics Department,

More information

Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness

Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Outline of Material Introduction

More information

Insulin Pump Therapy in children. Prof. Abdulmoein Al-Agha, FRCPCH(UK)

Insulin Pump Therapy in children. Prof. Abdulmoein Al-Agha, FRCPCH(UK) Insulin Pump Therapy in children Prof. Abdulmoein Al-Agha, FRCPCH(UK) aagha@kau.edu.sa Highlights Evolution of insulin pump Pumps mimics Pancreas Goals of diabetes care What lowers HbA1c Criteria for selection

More information

Advances in Diabetes Care Technologies

Advances in Diabetes Care Technologies 1979 Advances in Diabetes Care Technologies 2015 Introduction Roughly 20% - 30% of patients with T1DM and fewer than 1% of insulin-treated patients with T2DM use an insulin pump In 2007, the US FDA estimated

More information

Chapter 11. Nutrition and Fitness. Karen Schuster Florida Community College of Jacksonville. PowerPoint Lecture Slide Presentation created by

Chapter 11. Nutrition and Fitness. Karen Schuster Florida Community College of Jacksonville. PowerPoint Lecture Slide Presentation created by Chapter 11 Nutrition and Fitness PowerPoint Lecture Slide Presentation created by Karen Schuster Florida Community College of Jacksonville Copyright 2008 Pearson Education, Inc., publishing as Pearson

More information

Do fat and protein affect post prandial glycemia in the outpatient real world setting? Neha Verma, MD Robert Melfi, MD

Do fat and protein affect post prandial glycemia in the outpatient real world setting? Neha Verma, MD Robert Melfi, MD Do fat and protein affect post prandial glycemia in the outpatient real world setting? Neha Verma, MD Robert Melfi, MD Objectives Understand the effect of fat and protein on glycemic excursion in the post-prandial

More information

EAST OF ENGLAND CHILDREN AND YOUNG PEOPLE S DIABETES NETWORK. Optimising Glycaemic Control for Children and Young People with Diabetes

EAST OF ENGLAND CHILDREN AND YOUNG PEOPLE S DIABETES NETWORK. Optimising Glycaemic Control for Children and Young People with Diabetes EAST OF ENGLAND CHILDREN AND YOUNG PEOPLE S DIABETES NETWORK Optimising Glycaemic Control for Children and Young People with Diabetes Local diabetes teams need to take on the responsibility of ensuring

More information

Effect of a Short Sprint on Glucose Production and Whole Body Glucose Utilisation in Adults with Type 1 Diabetes

Effect of a Short Sprint on Glucose Production and Whole Body Glucose Utilisation in Adults with Type 1 Diabetes Effect of a Short Sprint on Glucose Production and Whole Body Glucose Utilisation in Adults with Type 1 Diabetes Avril Joy Fahey Bachelor of Science (Occupational Therapy) Bachelor of Science (Sport Science)

More information

Hormonal regulation of. Physiology Department Medical School, University of Sumatera Utara

Hormonal regulation of. Physiology Department Medical School, University of Sumatera Utara Hormonal regulation of nutrient metabolism Physiology Department Medical School, University of Sumatera Utara Homeostasis & Controls Successful compensation Homeostasis reestablished Failure to compensate

More information

Learning Objectives. At the conclusion of this module, participants should be better able to:

Learning Objectives. At the conclusion of this module, participants should be better able to: Learning Objectives At the conclusion of this module, participants should be better able to: Treat asymptomatic neonatal hypoglycemia with buccal dextrose gel Develop patient-specific approaches to intravenous

More information

BEST 4 Diabetes. Optimisation of insulin module

BEST 4 Diabetes. Optimisation of insulin module BEST 4 Diabetes Optimisation of insulin module Confidence and competence Where would you rate yourself? Why do all of our patient not achieve optimal blood glucose control? Insulin Therapy Goals and Purpose

More information

What are the Fuels the Body Uses for Activities?

What are the Fuels the Body Uses for Activities? What are the Fuels the Body Uses for Activities? Table 14-3, p. 485 Reviewing Aerobic Metabolism 1 Features of Aerobic Exercise Uses oxygen in the generation of energy Low intensity, long duration activity

More information

Food a fact of life eseminar: ENERGY REQUIREMENTS FOR SPORT. Dr Sarah Schenker British Nutrition Foundation

Food a fact of life eseminar: ENERGY REQUIREMENTS FOR SPORT. Dr Sarah Schenker British Nutrition Foundation Food a fact of life eseminar: ENERGY REQUIREMENTS FOR SPORT Dr Sarah Schenker British Nutrition Foundation Energy systems in the body Skeletal muscle is powered by ATP (adenosine triphosphate) Stores in

More information

Hormonal Regulations Of Glucose Metabolism & DM

Hormonal Regulations Of Glucose Metabolism & DM Hormonal Regulations Of Glucose Metabolism & DM What Hormones Regulate Metabolism? What Hormones Regulate Metabolism? Insulin Glucagon Thyroid hormones Cortisol Epinephrine Most regulation occurs in order

More information

Exercise in Closed-Loop Control Bon, Arianne C. van; Verbitskiy, Evgeny; Basum, Golo von; Hoekstra, Joost B.L.; Vries, J. Hans de

Exercise in Closed-Loop Control Bon, Arianne C. van; Verbitskiy, Evgeny; Basum, Golo von; Hoekstra, Joost B.L.; Vries, J. Hans de University of Groningen Exercise in Closed-Loop Control Bon, Arianne C. van; Verbitskiy, Evgeny; Basum, Golo von; Hoekstra, Joost B.L.; Vries, J. Hans de Published in: Journal of Diabetes Science and Technology

More information

28 Regulation of Fasting and Post-

28 Regulation of Fasting and Post- 28 Regulation of Fasting and Post- Prandial Glucose Metabolism Keywords: Type 2 Diabetes, endogenous glucose production, splanchnic glucose uptake, gluconeo-genesis, glycogenolysis, glucose effectiveness.

More information

Diabetes mellitus is when the pancreas (a gland near the stomach) does not produce enough insulin to properly regulate blood glucose levels.

Diabetes mellitus is when the pancreas (a gland near the stomach) does not produce enough insulin to properly regulate blood glucose levels. DIABETES MELLITUS What is Diabetes Mellitus? Level 1, 26 Robertson St Kensington 3031 VIC Australia T (03) 9092 0400 F (03) 9376 8567 info@advancedvetcare.com.au... ABN 29 814 586 915 Diabetes mellitus

More information

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016 Diabetes Mellitus Raja Nursing Instructor 09/03/2016 Acknowledgement: Badil Objective: Define Diabetes Mellitus (DM) & types of DM. Understand the pathophysiology of Type-I & II DM. List the clinical features

More information

Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna. Ipoglicemie e Monitoraggio Glicemico

Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna. Ipoglicemie e Monitoraggio Glicemico Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna Ipoglicemie e Monitoraggio Glicemico Management of Hypoglycaemia.if hypoglycemia is a problem, the principles

More information

This certificate-level program is non-sponsored.

This certificate-level program is non-sponsored. Program Name: Diabetes Education : A Comprehensive Review Module 5 Intensive Insulin Therapy Planning Committee: Michael Boivin, B. Pharm. Johanne Fortier, BSc.Sc, BPh.LPh, CDE Carlene Oleksyn, B.S.P.

More information

9/11/2012. Chapter 11. Learning Objectives. Learning Objectives. Endocrine Emergencies. Differentiate type 1 and type 2 diabetes

9/11/2012. Chapter 11. Learning Objectives. Learning Objectives. Endocrine Emergencies. Differentiate type 1 and type 2 diabetes Chapter 11 Endocrine Emergencies Learning Objectives Differentiate type 1 and type 2 diabetes Explain roles of glucagon, glycogen, and glucose in hypoglycemia Learning Objectives Discuss following medications

More information

Artificial Pancreas Device Systems. Populations Interventions Comparators Outcomes Individuals: With type 1 diabetes

Artificial Pancreas Device Systems. Populations Interventions Comparators Outcomes Individuals: With type 1 diabetes Protocol Artificial Pancreas Device Systems Medical Benefit Effective Date: 07/01/18 Next Review Date: 01/20 Preauthorization Yes Review Dates: 03/15, 03/16, 03/17, 01/18, 05/18, 01/19 Preauthorization

More information

Endocrinology and the Athlete. Objectives

Endocrinology and the Athlete. Objectives Endocrinology and the Athlete Paul Thornton, MD Medical Director Endocrinology Objectives Overview of type 1 diabetes Impact of type 1 diabetes on athletic performance Management of type 1 diabetes daily

More information

THE SHEFFIELD AREA PRESCRIBING GROUP. Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes. Date: March 2018.

THE SHEFFIELD AREA PRESCRIBING GROUP. Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes. Date: March 2018. THE SHEFFIELD AREA PRESCRIBING GROUP Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes Date: March 2018 Overview Freestyle Libre is a flash glucose sensor device that measures *interstitial

More information

GLP-1 agonists. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK

GLP-1 agonists. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK GLP-1 agonists Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK What do GLP-1 agonists do? Physiology of postprandial glucose regulation Meal ❶ ❷ Insulin Rising plasma

More information

Advances in Diabetes Care Technologies

Advances in Diabetes Care Technologies Advances in Diabetes Care Technologies 1979 2015 Introduction Roughly 20% to 30% of patients with T1DM and fewer than 1% of insulin-treated patients with T2DM use an insulin pump In 2007, the U.S. FDA

More information

10. ACUTE COMPLICATIONS OF DIABETES MELLITUS

10. ACUTE COMPLICATIONS OF DIABETES MELLITUS 10. ACUTE COMPLICATIONS OF DIABETES MELLITUS Prof. Oren Zinder, Ph.D. Rambam Medical Center, and the Technion Faculty of Medicine, Haifa, Israel 1.1. Hypoglycaemia Hypoglycaemia is a lowered blood glucose

More information

EB Education Revision Guide. How to work with Homeostasis: Part 2 Blood Glucose Regulation

EB Education Revision Guide. How to work with Homeostasis: Part 2 Blood Glucose Regulation EB Education Revision Guide How to work with Homeostasis: Part 2 Blood Glucose Regulation Blood Glucose Regulation a) Why your body regulates glucose levels What you need to know about Homeostasis: Part

More information

CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER

CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER Case 1: CGM use during pregnancy 29 yo G1P0000 at 10 5/7 weeks gestation presents to set

More information

Exercise Prescription in Type 1 Diabetes

Exercise Prescription in Type 1 Diabetes Exercise Prescription in Type 1 Diabetes Michael Riddell, PhD Professor, Muscle Health Research Centre and School of Kinesiology & Health Science, York University Senior Scientist, LMC Diabetes & Endocrinology,

More information

Diabetes Management: Current High Tech Innovations

Diabetes Management: Current High Tech Innovations Diabetes Management: Current High Tech Innovations How Far We ve Come in the Last 40 Years William V. Tamborlane, MD Department of Pediatrics Yale School of Medicine Disclosures I am a consultant for:

More information

HAUTE ROUTE 3 DAY EVENT

HAUTE ROUTE 3 DAY EVENT TRAINING PLAN 3 DAY EVENT WATTBIKE.COM 3 DAY EVENT TRAINING PLAN ABOUT THE 3 DAY EVENT The Haute Route three day events are tough, endurance challenges. The three stages take in famous roads and parcours

More information

What is a CGM? (Continuous Glucose Monitor) The Bionic Pancreas Is Coming

What is a CGM? (Continuous Glucose Monitor) The Bionic Pancreas Is Coming The Bionic Pancreas Is Coming Montana Diabetes Professional Conference October 23, 2014 H. Peter Chase, MD Professor of Pediatrics University of Colorado Barbara Davis Center Stanford: Bruce Buckingham,

More information

Chapter 4. Exercise Metabolism

Chapter 4. Exercise Metabolism Chapter 4 Exercise Metabolism Rest to Exercise Transition Step onto a treadmill at 6 mph In one step muscles increase ATP production What metabolic changes occur? From rest to light or moderate exercise

More information

Policy for Continuous Glucose Monitoring for Type 1 Diabetic Paediatric Patients (<18 years of age)

Policy for Continuous Glucose Monitoring for Type 1 Diabetic Paediatric Patients (<18 years of age) Policy for Continuous Glucose Monitoring for Type 1 Diabetic Paediatric Patients (

More information

Activity and Diabetes: Benefits, Precautions and Guidelines. Shay Kelly BS, MSS, BSN, CDE. Program Objectives

Activity and Diabetes: Benefits, Precautions and Guidelines. Shay Kelly BS, MSS, BSN, CDE. Program Objectives Activity and Diabetes: Benefits, Precautions and Guidelines Shay Kelly BS, MSS, BSN, CDE Program Objectives At the end of this presentation, the participant will be able to: 1. Describe how the body utilizes

More information

Placename CCG. Policies for the Commissioning of Healthcare

Placename CCG. Policies for the Commissioning of Healthcare Placename CCG Policies for the Commissioning of Healthcare Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus. This document is part

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our

More information

Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES

Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES Many parents whose child is diagnosed with Type 1 diabetes wonder: Why is this happening to my child?

More information

MANAGEMENT OF TYPE 1 DIABETES MELLITUS

MANAGEMENT OF TYPE 1 DIABETES MELLITUS MANAGEMENT OF TYPE 1 DIABETES MELLITUS INVESTIGATIONS AND TREATMENT MANSI NAIK VII SEMESTER INVESTIGATIONS FASTING BLOOD SUGAR PLASMA GLUCOSE HEMOGLOBIN A 1c SYMPTOMS OF TYPE 1 DIABETES MELLITUS Polyuria

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS Revised: October 2010 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Caninsulin 40 iu/ml Suspension for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:

More information

Goals & Objectives. Diabetes Mellitus

Goals & Objectives. Diabetes Mellitus Rudy R. Navarro, M.D., CAQSM Department of Family & Community Medicine UT Health Science Center at San Antonio Goals & Objectives Understand the patterns of glucose utilization during exercise and sporting

More information

Insulin Pumps and Glucose Sensors in Diabetes Management

Insulin Pumps and Glucose Sensors in Diabetes Management Diabetes Update+ 2014 Congress Whistler, British Columbia Friday March 21, 2014ǀ 8:15 8:45 am Insulin Pumps and Glucose Sensors in Diabetes Management Bruce A Perkins MD MPH Division of Endocrinology Associate

More information

5.0 HORMONAL CONTROL OF CARBOHYDRATE METABOLISM

5.0 HORMONAL CONTROL OF CARBOHYDRATE METABOLISM 5.0 HORMONAL CONTROL OF CARBOHYDRATE METABOLISM Introduction: Variety of hormones and other molecules regulate the carbohydrates metabolism. Some of these have already been cited in previous sections.

More information

Energy metabolism - the overview

Energy metabolism - the overview Energy metabolism - the overview Josef Fontana EC - 40 Overview of the lecture Important terms of the energy metabolism The overview of the energy metabolism The main pathways of the energy metabolism

More information

Long-term effects of continuous glucose monitoring on HbA 1c levels: An audit

Long-term effects of continuous glucose monitoring on HbA 1c levels: An audit Long-term effects of continuous glucose monitoring on Julie Brake Continuous glucose monitoring (CGM) has become a common and useful tool in diabetes care. To understand whether a 72-hour glucose profile

More information

Carbohydrate Metabolism

Carbohydrate Metabolism Chapter 34 Carbohydrate Metabolism Carbohydrate metabolism is important for both plants and animals. Introduction to General, Organic, and Biochemistry, 10e John Wiley & Sons, Inc Morris Hein, Scott Pattison,

More information

DISCOVER THE POWER OF CONNECTION MINIMED 640G

DISCOVER THE POWER OF CONNECTION MINIMED 640G DISCOVER THE POWER OF CONNECTION MINIMED 640G INSULIN PUMP THERAPY CHANGING LIVES TODAY Have you just been diagnosed with insulin dependent diabetes? Perhaps you ve been on multiple daily injection therapy

More information

Regular physical activity is associated

Regular physical activity is associated Prevention of Exercise-Associated Dysglycemia: A Case Study Based Approach Dessi P. Zaharieva and Michael C. Riddell School of Kinesiology and Health Science & Muscle Health Research Center, Toronto, Ontario,

More information

MAKING THE MOST OF MUSCLE There s more to muscle than fast-twitch and slow-twitch By Dario Fredrick

MAKING THE MOST OF MUSCLE There s more to muscle than fast-twitch and slow-twitch By Dario Fredrick MAKING THE MOST OF MUSCLE There s more to muscle than fast-twitch and slow-twitch By Dario Fredrick [Velo News, Vol. 33/No. 19, December 20, 2004] Most cyclists will tell you they ve heard of slow- and

More information

Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical

Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical Practice Guideline Task Force Members Anne Peters, MD (Chair)

More information

Initiation and Titration of Insulin in Diabetes Mellitus Type 2

Initiation and Titration of Insulin in Diabetes Mellitus Type 2 Initiation and Titration of Insulin in Diabetes Mellitus Type 2 Greg Doelle MD, MS April 6, 2016 Disclosure I have no actual or potential conflicts of interest in relation to the content of this lecture.

More information

Type 1 Diabetes and Sports Nutrition

Type 1 Diabetes and Sports Nutrition Type 1 Diabetes and Sports Nutrition Type 1 diabetes is a condition in which the body is unable to produce insulin. Without insulin, the body's ability to use glucose as a fuel source is impaired. Does

More information

Interpretation and management of fasting hyperglycaemia in adults with Type 1 diabetes using MDI insulin regimen

Interpretation and management of fasting hyperglycaemia in adults with Type 1 diabetes using MDI insulin regimen Interpretation and management of fasting hyperglycaemia in adults with Type 1 diabetes using MDI insulin regimen For many years it was believed that high blood glucose (BG) levels first thing in the morning

More information

Hypoglycemia. When recognized early, hypoglycemia can be treated successfully.

Hypoglycemia. When recognized early, hypoglycemia can be treated successfully. Hypoglycemia Introduction Hypoglycemia is a condition that causes blood sugar level to drop dangerously low. It mostly shows up in diabetic patients who take insulin. When recognized early, hypoglycemia

More information

Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond)

Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond) Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond) 9501366-011 20110401 Objectives Understand the need for insulin pumps and CGMS in managing

More information

WOULD YOU LIKE MORE CONFIDENCE IN YOUR HYPOGLYCAEMIC CONTROL? SMARTGUARD. PROVIDES PREDICTIVE PROTECTION

WOULD YOU LIKE MORE CONFIDENCE IN YOUR HYPOGLYCAEMIC CONTROL? SMARTGUARD. PROVIDES PREDICTIVE PROTECTION WOULD YOU LIKE MORE CONFIDENCE IN YOUR HYPOGLYCAEMIC CONTROL? SMARTGUARD. PROVIDES PREDICTIVE PROTECTION 1,2 MINIMED 640G WITH SMARTGUARD HAVE YOU CONSIDERED THE REAL IMPACT HYPOGLYCAEMIA HAS ON YOUR LIFE?

More information